CB1 Receptors in Human Brown Adipose Tissue

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2017-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates cannabinoid CB1 receptors in human brown adipose tissue (BAT) and other tissues using positron emission tomography (PET) imaging. Subjects will be scanned in room temperature conditions and during controlled cold exposure, and the density of CB1 receptors in BAT and other tissues will be quantified. The investigators hypothesize, that cannabinoid signaling is increased in cold conditions, when BAT is metabolically active.

Understanding the mechanisms of BAT activation and the role of endocannabinoids in humans is important and beneficial in fighting against the epidemic of obesity and diabetes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion

NCT04940962

Diabete Type 2 Abdominal Obesity

RECRUITING NA

Longitudinal Follow-up of Brown Adipose Tissue Function and Structure

NCT01985503

Obesity

COMPLETED

Adenosine and A2A Receptors in Human Brown Adipose Tissue

NCT03327168

Obesity

COMPLETED NA

Brown Fat Activation and Browning Efficiency Augmented by Chronic Cold and Nutraceuticals for Brown Adipose Tissue-mediated Effect Against Metabolic Syndrome (BEACON BEAMS Study)

NCT04595006

Energy Expenditure Obesity Brown Adipose Tissue

ACTIVE_NOT_RECRUITING NA

Brown Adipose Tissue and Body Mass Index

NCT02173834

Obesity Type 2 Diabetes Mellitus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endocannabinoids have an important role in regulating energy balance and metabolism. Cannabinoid 1 receptors (CB1) are found in several tissues such as brown adipose tissue (BAT). Endocannabinoids and CB1 receptors participate in the control of lipid and glucose metabolism, and blockage of CB1 receptors has been found to improve metabolic factors linked to obesity and cardiovascular disease, making CB1 antagonists potential drugs against obesity and diabetes.

In this study the investigators use a PET radiotracer \[18F\]FMPEP-d2, which binds to CB1 receptors in vivo, to quantify the CB1 receptor density in BAT, white adipose tissue, muscle and the brain. This study is done once in warm conditions and once during controlled cold exposure. To verify whether the subject has metabolically active BAT, an additional PET scan with the radiotracer \[18F\]FDG is performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

[18F]FMPEP-d2 in warm conditions

PET scan is performed using PET radiotracer \[18F\]FMPEP-d2 in standard room temperature conditions.

Group Type OTHER

[18F]FMPEP-d2

Intervention Type OTHER

PET radiotracer used in imaging

[18F]FMPEP-d2 in cold conditions

PET scan is performed using PET radiotracer \[18F\]FMPEP-d2 during controlled cold exposure.

Group Type OTHER

Cold exposure

Intervention Type OTHER

Controlled cold exposure is performed before and during PET scan

[18F]FMPEP-d2

Intervention Type OTHER

PET radiotracer used in imaging

[18F]FDG in cold conditions

PET scan is performed using PET radiotracer \[18F\]FDG during controlled cold exposure.

Group Type OTHER

Cold exposure

Intervention Type OTHER

Controlled cold exposure is performed before and during PET scan

[18F]FDG

Intervention Type OTHER

PET radiotracer used in imaging

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cold exposure

Controlled cold exposure is performed before and during PET scan

Intervention Type OTHER

[18F]FMPEP-d2

PET radiotracer used in imaging

Intervention Type OTHER

[18F]FDG

PET radiotracer used in imaging

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteer
* Group 1: BMI 20-26 kg/m2, Group2: BMI 27-40 kg/m2

Exclusion Criteria

* BMI \< 20 kg/m2or BMI \> 40 kg/m2
* Any chronic disease that could affect the study outcome, including medicated type 2 diabetes
* Mental disorder or poor compliance
* Eating disorder or excessive use of alcohol, tobacco smoking or drug use
* Past dose of radiation
* Presence of any ferromagnetic objects that would make MR imaging contraindicated
* Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes